Kimino Minagawa, Takashi Hayakawa, Hayato Akimoto, Takuya Nagashima, Yasuo Takahashi, Satoshi Asai. Late development of OCD-like phenotypes in Dlgap1 knockout mice. Psychopharmacology. 2024
Hayato Akimoto, Takashi Hayakawa, Takuya Nagashima, Kimino Minagawa, Yasuo Takahashi, Satoshi Asai. Detection of potential drug-drug interactions for risk of acute kidney injury: a population-based case-control study using interpretable machine-learning models. Frontiers in Pharmacology. 2023. 14
Takashi Hayakawa, Takuya Nagashima, Hayato Akimoto, Kimino Minagawa, Yasuo Takahashi, Satoshi Asai. Benzodiazepine-related dementia risks and protopathic biases revealed by multiple-kernel learning with electronic medical records. DIGITAL HEALTH. 2023. 9. 205520762311785-205520762311785
Hayato Akimoto, Takuya Nagashima, Kimino Minagawa, Takashi Hayakawa, Yasuo Takahashi, Satoshi Asai. Detection of Synergistic Interaction on an Additive Scale Between Two Drugs on Abnormal Elevation of Serum Alanine Aminotransferase Using Machine-Learning Algorithms. Frontiers in Pharmacology. 2022. 13. 910205
Identifying Antidepressants Less Likely to Cause Hyponatremia: Triangulation of Retrospective Cohort, Disproportionality, and Pharmacodynamic Studies. Clinical Pharmacology & Therapeutics. 2022. 111. 6. 1258-1267
Association between use of oral hypoglycemic agents in Japanese patients with type 2 diabetes mellitus and risk of depression: a retrospective cohort study
(第93回日本薬理学会年会 2020)